Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
6.96
+0.08 (1.16%)
At close: Sep 11, 2025, 4:00 PM EDT
6.62
-0.34 (-4.89%)
After-hours: Sep 11, 2025, 4:00 PM EDT
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $144.62 million as of September 11, 2025. Its market cap has decreased by -6.35% in one year.
Market Cap
144.62M
Enterprise Value
139.17M
1-Year Change
-6.35%
Ranking
Category
Stock Price
6.96
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $144.62M, a decrease of -4.93%. That is a compound annual growth rate of -4.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2025 | 142.96M | -8.05% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 673.85B |
| Johnson & Johnson | 426.18B |
| AbbVie | 371.72B |
| UnitedHealth Group | 315.10B |
| AstraZeneca | 251.31B |
| Novartis AG | 248.23B |
| Novo Nordisk | 236.38B |
| Abbott Laboratories | 229.65B |